Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;100(3):510-516.e6.
doi: 10.1016/j.gie.2024.02.001. Epub 2024 Feb 7.

Establishment of standards for the referral of large nonpedunculated colorectal polyps: an international expert consensus using a modified Delphi process

Affiliations

Establishment of standards for the referral of large nonpedunculated colorectal polyps: an international expert consensus using a modified Delphi process

Kareem Khalaf et al. Gastrointest Endosc. 2024 Sep.

Abstract

Background and aims: Resection of colorectal polyps has been shown to decrease the incidence and mortality of colorectal cancer. Large nonpedunculated colorectal polyps are often referred to expert centers for endoscopic resection, which requires relevant information to be conveyed to the therapeutic endoscopist to allow for triage and planning of resection technique. The primary objective of this study was to establish minimum expected standards for the referral of large nonpedunculated colonic polyps for potential endoscopic resection.

Methods: A Delphi method was used to establish consensus on minimum expected standards for the referral of large colorectal polyps among a panel of international endoscopy experts. The expert panel was recruited through purposive sampling, and 3 rounds of surveys were conducted to achieve consensus. Quantitative and qualitative data were analyzed for each round.

Results: A total of 24 international experts from diverse continents participated in the Delphi study, resulting in consensus on 19 statements related to the referral of large colorectal polyps. The identified factors, including patient demographic characteristics, relevant medications, lesion factors, photodocumentation, and the presence of a tattoo, were deemed important for conveying the necessary information to therapeutic endoscopists. The mean scores for the statements, which were scored on a scale of 1 to 10, ranged from 7.04 to 9.29, with high percentages of experts considering most statements as a very high priority. Subgroup analysis according to continent revealed some variations in consensus rates among experts from different regions.

Conclusions: The identified consensus statements can aid in improving the triage and planning of resection techniques for large colorectal polyps, ultimately contributing to the reduction of colorectal cancer incidence and mortality.

PubMed Disclaimer

Conflict of interest statement

Disclosure The following authors disclosed financial relationships: A. Sethi: consultant for Boston Scientific, Interscope, Medtronic, and Olympus; research support from Boston Scientific and Fujifilm; advisory board member for Endosound. K. Mönkemüller: consultant for Ovesco USA and Ovesco Germany. T. Pavic: speaker for Olympus and Boston Scientific. M. J. Bourke: research support for ethics-approved studies from Cook Medical, Olympus Medical, and Boston Scientific. P. Saxena: consultant for Boston Scientific, Ambu, and Erbe. D. K. Rex: Consultant for Olympus Corporation, Boston Scientific, Braintree Laboratories, Norgine, Medtronic, and Acacia Pharmaceuticals; research support from Olympus Corporation, Medivators, Erbe USA Inc, and Braintree Laboratories; shareholder with Satisfai Health. U. D. Siddiqui: research, consultant, and speaker for Olympus and Boston Scientific; and consultant and speaker for CONMED, Cook, and Medtronic. M. Pellisé: clinical advisory boards for Fujifilm Europe and Olympus; clinical advisory board and share options in MiWEndo; speaker fees from Casen Recordati, Norgine Iberia, Fujifilm, Mayoli, Medtronic, and Olympus; and research funding from Fujifilm, Casen Recordati, Ziuz, and 3-D Matrix. J. D. Mosko: Consulting: Boston Scientific, Fuji, Medtronic, Pendopharm, and Steris; research funding from Boston Scientific and Vantage/ERBE. C. W. Teshima: speaker for Medtronic and Boston Scientific; and consultant for Boston Scientific. G. R. May: consultant for Olympus; and speaker for Pentax, Fuji, and Medtronic. S. C. Grover: research grants and personal fees from AbbVie and Ferring Pharmaceuticals; personal fees from Takeda, Sanofi, and BioJAMP; education grants from Janssen; and equity shares in Volo Healthcare. C. Hassan: consultant for Fujifilm and Medtronic; and research grants from Fujifilm and NEC. A. Repici: consultant for Fujifilm, Olympus Corp, and Medtronic; and research grants from Fujifilm and NEC. P. Sharma: consultant for Olympus Corporation, Boston Scientific, Salix Pharmaceuticals, Cipla, Medtronic, Takeda, Samsung Bioepis, and CDx; and grant support from ERBE and Fujifilm. R. Bechara: consultant for Olympus, Pentax, Vantage, Medtronic, and Pendopharm. A. Shaukat: Consultant for Itertive Health, Freenome, UniversalDx, and Motus GI. All other authors disclosed no relevant financial disclosures or conflicts of interest to declare. The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors.

LinkOut - more resources